Ann: Preliminary Final Report, page-2

REVENUE
Revenue from all ordinary activities was $24 million, up 595% over FY2016. Top-line growth during the second year of true commercial sales further solidifies Alexium’s strong position in the specialty chemical supply market.

MARGINS
Following initial lower margin business in FY2016 used to establish demonstrable supply chain reliability and initial market penetration, FY2017 gross margins on chemical sales improved from -12.08% to 1.24 %. Reaching economies of scale with supply chain partners and rapid growth in 2H2017 from our Alexicool™ product line provided the foundation for realizing positive margins, culminating with June 2017 monthly margins of 30.6%. This positive trend has continued through the reporting date closer to a margin goal of greater than 40%

http://www.aspecthuntley.com.au/doc...lc2lnbmFsL2Vycm9ycGFnZXMvcGRmZGVsYXllZC5qc3A=